US 8188061
RNAi modulation of APOB and uses thereof
granted A61KA61K31/7105A61K31/718
Quick answer
US patent 8188061 (RNAi modulation of APOB and uses thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/7105, A61K31/718, A61P, A61P3/00